Activity of CM-40874 against Enterobacter resistant to third generation cephalosporins.
García-Rodriguez
J A
JA
Salamanca University, Clinical Hospital department of Microbiology, Spain.
García-Sánchez
J E
JE
García-García
M I
MI
García-Sánchez
E
E
Munõz-Bellido
J L
JL
Trujillano
I
I
D002439:Cefotaxime / Q000494:pharmacology; D002442:Ceftazidime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000187:drug effects / Q000235:genetics*; D006193:Haemophilus influenzae / Q000187:drug effects / Q000235:genetics; D006801:Humans; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000235:genetics
D002511:Cephalosporins; C041589:CM 40874; D002442:Ceftazidime; D002439:Cefotaxime